Attention-Deficit/ Hyperactivity Disorder (ADHD). Attention-deficit hyperactivity disorders
Conditions
Interventions
Intervention group: Children receiving atomoxetine at a daily dose of 10 mg for 12 weeks.
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
4 Years to 12 Years
Inclusion criteria
Inclusion criteria: No history of atomoxetine use, informed consent from parents to participate in the study, diagnosis of ADHD according to the assessment of a pediatric neurologist
Exclusion criteria
Exclusion criteria: The presence of other neurological and psychiatric disorders alongside the diagnoses made by pediatric neurologists
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADHD rating scale. Timepoint: before intervention and 4, 8 , 12 months after intervention. Method of measurement: ADHD Rating Scale Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Revised Connors Parent Scale score. Timepoint: before intervention and 4, 8 , 12 months after intervention. Method of measurement: Revised Connors Parent Scale Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ahad Ghazavi
Oroumia University of Medical Sciences
Outcome results
None listed